Helping people with HIV who smoke cigarettes reduce harm
Trial of a harm reduction strategy for people with HIV who smoke cigarettes
This study is designed to help people with HIV who smoke cigarettes by providing support and medication to help them quit, along with resources for those who may still smoke, all aimed at improving their overall health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11078816 on NIH RePORTER |
What this research studies
This research aims to support individuals living with HIV who smoke cigarettes by evaluating a harm reduction strategy. Participants will receive a combination of behavioral support and medication to help them quit smoking, along with additional resources for those who continue to smoke. The study includes an informational video to encourage smoking reduction and offers lung cancer screening and referrals for health management based on individual health metrics. The goal is to improve overall health outcomes for this population.
Who could benefit from this research
Good fit: Ideal candidates are individuals living with HIV who currently smoke cigarettes.
Not a fit: Patients who do not smoke or are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health and reduced smoking-related risks for people living with HIV.
How similar studies have performed: Previous research has shown promise in harm reduction strategies for smoking cessation, indicating potential for success in this approach.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Shuter, Jonathan — Albert Einstein College of Medicine
- Study coordinator: Shuter, Jonathan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.